By staff writers

February 13, 2019 -- Mevion Medical Systems has signed a contract with Allcure Kangtai Proton Technology in China for the purchase of a Mevion S250i proton therapy system.

The device features the company's Hyperscan pencil-beam scanning technology to deliver conformal fields of radiation therapy to tumors.

Mevion sold four S250i proton therapy systems in 2018. The sale to Allcure Kangtai is the company's first in the Asia-Pacific region.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking